Merck

study

Efinopegdutide Produces Strong Histologic Responses in Phase 2b MASH Study

Patient Worthy · 8h ago

detranslation pending

Merck hebt erneut die Ziele an

Deutsches Ärzteblatt · 12h ago

study

Drug Approval Marks Another Win for Merck KGaA’s Rare Tumor Strategy

MedCity News · 1d ago

Merck's rare tumour drug Pimjetmi claims FDA approval

Pharmaphorum · 1d ago

FDA approves neoadjuvant/ adjuvant pembrolizumab for resectable non-small cell lung cancer

FDA Drug Safety / Drugs feed · 2d ago

FDA approves enfortumab vedotin-ejfv with pembrolizumab for locally advanced or metastatic urothelial cancer

FDA Drug Safety / Drugs feed · 2d ago

FDA approves belzutifan for advanced renal cell carcinoma

FDA Drug Safety / Drugs feed · 2d ago

FDA approves pembrolizumab with chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma

FDA Drug Safety / Drugs feed · 2d ago

FDA approves pembrolizumab with chemotherapy for unresectable advanced or metastatic malignant pleural mesothelioma

FDA Drug Safety / Drugs feed · 2d ago

FDA approves pembrolizumab for esophageal or GEJ carcinoma

FDA Drug Safety / Drugs feed · 2d ago

FDA approves pembrolizumab with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer

FDA Drug Safety / Drugs feed · 2d ago

FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer

FDA Drug Safety / Drugs feed · 2d ago

FDA approves new and updated indications for temozolomide under Project Renewal

FDA Drug Safety / Drugs feed · 2d ago

FDA grants accelerated approval to enfortumab vedotin-ejfv with pembrolizumab for locally advanced or metastatic urothelial carcinoma

FDA Drug Safety / Drugs feed · 3d ago

Lonza ups the ante in US with Merck KGaA deal, Samsung Biologics must respond

Pharma Manufacturing · 3d ago

FDA approves belzutifan with pembrolizumab for adjuvant treatment of renal cell carcinoma

FDA Drug Safety / Drugs feed · 6d ago

FDA approves belzutifan in combination with lenvatinib for advanced renal cell carcinoma with a clear cell component

FDA Drug Safety / Drugs feed · 6d ago

interview

[Interview] Merck Life Science CEO calls Daejeon its most advanced smart manufacturing site

Korea Biomedical Review · 6d ago

ro

Companies can support the birth rate with measures for employees who want children and those with fertility problemsCompaniile pot sprijini natalitatea prin măsuri pentru angajații care își doresc copii și pentru cei cu probleme de fertilitate

Politici de Sănătate · 7d ago

Lonza Expanding U.S. CDMO Footprint with Purchase of Five Merck KGaA Sites

GEN Genetic Engineering News · 8d ago

es

Merck excludes Peru from generic licences for an HIV drug tested in the countryMerck excluye a Perú de las licencias para genéricos de un medicamento contra el VIH probado en el país

Salud con Lupa · 8d ago

opinion

Cancer Vaccines Show Promise. But We Have More Work to Do.

MedPage Today · 8d ago

German Merck divests its US CDMO business

Life Science Sweden · 8d ago

Lonza agrees to buy 5 Merck KGaA facilities to accelerate US expansion

BioSpace · 9d ago

Merck charts course out of CDMO business with Lonza sale

Pharmaphorum · 9d ago

Lonza to acquire five CDMO sites from Merck KGaA, more than doubling US footprint

Pharma Manufacturing · 9d ago

BioPharma Dive · 10d ago

Pembrolizumab extends PFS in endometrial cancer subset

Healio · 10d ago

study

Assessing Merck and Moderna’s mRNA cancer vaccine

STAT News · 13d ago

Merck Revenue Up on Keytruda, Winrevair Growth

WSJ Health · 14d ago

interview

Q&A: Could a new melanoma vaccine change cancer treatment?

Medical Xpress · 16d ago

review

Merck drug extends survival in endometrial cancer trial, wins U.S. priority review

The Hindu Health · 16d ago

study

STAT+: Merck ADC drug cut risk of death by one-third in advanced endometrial cancer

STAT News · 17d ago

study

Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer

NPR Health · 17d ago

STAT+: Moderna CEO on what’s next after success in cancer vaccine

STAT Biotech · 17d ago

Milestone cancer vaccine success leaves hard questions unanswered

Science Magazine News · 17d ago

estranslation pending

Las vacunas contra el cáncer: sí, pero aún no

El País Salud y Bienestar · 18d ago

estranslation pending

Premian un desarrollo científico que busca optimizar las cirugías de epilepsias que no responden a la medicación

Agencia CyTA (Leloir) · 20d ago

detranslation pending

mRNA-Impfstoff: Impfstoff senkt laut Studie Rückfall bei Hautkrebs um 42 Prozent

Zeit Gesundheit · 20d ago

pttranslation pending

Vacina de mRNA contra câncer reduz em 42% risco de morte ou volta do melanoma

G1 Saúde · 20d ago

eltranslation pending

Μελάνωμα: Εξατομικευμένο εμβόλιο mRNA για τον καρκίνο μείωσε κατά 42% τον κίνδυνο υποτροπής ή θανάτου

Naftemporiki Υγεία · 20d ago

study

Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report

NYT Well · 21d ago

UAE Experts Urge Parents to Pay Closer Attention to Children’s Growth

Middle East Health · 31d ago

estranslation pending

Laboratorios Moderna y Merck anuncian buenos resultados de una vacuna contra el cáncer de piel

RPP Vital · 85d ago

Sources

Coverage